Peter Fedichev

Peter Fedichev, founder of Gero, and Aleksandr Sviridov dive into the intriguing world of longevity science. They discuss how physics can illuminate aging processes and the significance of creating standardized aging models. The conversation spans innovative data utilization, from plasma proteomics to wearable tech, in advancing anti-aging therapies. They also explore the exciting possibilities of epigenetic rejuvenation, organ replacement, and the collaborative efforts needed in the field to push boundaries, emphasizing prevention alongside repair.

Dr. Peter Fedichev, PhD, is the CEO of Gero, where he employs AI and digital biomarkers to tackle aging and complex diseases. He discusses his transition from physics to biotech, highlighting the importance of resilience in aging through longitudinal data. Peter introduces the concept of thermodynamic biological age and examines unique insights from naked mole-rats. He emphasizes the power of AI in drug repurposing and shares Gero's ambitious plans for enhancing the human healthspan, inviting collaboration on groundbreaking scientific advancements.

Peter Fedichev, a physicist-turned-biotech innovator and CEO of Gero, dives into the intricacies of aging. He explains how resilience, rather than disease, is key to longevity and frames aging as a series of 'jumps' in physiology. Peter advocates for startups as the future of longevity research, highlights the importance of molecular fidelity, and discusses the limitations of animal models in aging studies. His insights on personal longevity practices and the role of social factors offer listeners a fresh perspective on enhancing healthspan.